Unexpected PD‐L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies

Unexpected PD‐L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies

Abstract Lack of effective immune infiltration represents a significant barrier to immunotherapy in solid tumors. Thus, solid tumor‐enriched death receptor‐5 (DR5) activating antibodies, which generates tumor debulking by extrinsic apoptotic cytotoxicity, remains a crucial alternate therapeutic stra...

Full description

Bibliographic Details
Main Authors: Tanmoy Mondal, Gururaj N Shivange, Rachisan GT Tihagam, Evan Lyerly, Michael Battista, Divpriya Talwar, Roxanna Mosavian, Karol Urbanek, Narmeen S Rashid, J Chuck Harrell, Paula D Bos, Edward B Stelow, M Sharon Stack, Sanchita Bhatnagar, Jogender Tushir‐Singh
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:EMBO Molecular Medicine
Subjects:
DR5
dual‐specificity antibodies
immune evasion
PD‐L1
solid tumors
Online Access:https://doi.org/10.15252/emmm.202012716

Internet

https://doi.org/10.15252/emmm.202012716

Similar Items